Efficacy Study Of Oral Glecaprevir/Pibrentasvir Tablet In Pediatric (12 Years and Older) And Adult Treatment-Naive Participants With Chronic Hepatitis C Genotypes 1 To 6 And Liver Cirrhosis

CompletedOBSERVATIONAL
Enrollment

99

Participants

Timeline

Start Date

May 29, 2020

Primary Completion Date

June 11, 2021

Study Completion Date

June 11, 2021

Conditions
Hepatitis C Virus (HCV)
Trial Locations (6)

302038

S. P. Botkin City Hospital /ID# 225500, Oryol

355017

Stavropol State Medical University /ID# 226589, Stavropol

432063

Medical center Academy /ID# 226587, Ulyanovsk

443029

Samara Region Clinical HIV/AIDS Prevention and Control Center /ID# 222582, Samara

454052

South Ural State Medical University /ID# 225501, Chelyabinsk

664035

Irkutsk Regional Center for the Prevention and Control of AIDS and Infections /ID# 225499, Irkutsk

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY